3-Methyl-2-(4-Chlorophenyl)Butyryl Chloride

We are 3-Methyl-2-(4-Chlorophenyl)Butyryl Chloride CAS:51631-50-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Related News: The mode of cooperation between domestic API companies and large international companies can lower the export threshold.2,3-difluoro-5-metilbenzonitrilo CAS:1003712-18-2 The mode of cooperation between domestic API companies and large international companies can lower the export threshold.cis-3-(2-Chloro-3,3,3-trifluoroprop-1-en-1-yl)-2,2-dimethylcyclopropanecarboxylic acid CAS:72748-35-7 Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.2-[3-(Dimethylamino)propionyl]thiophene Hydrochloride CAS:5424-47-5 Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).